(EN) Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Non Small Cell Lung Cancer: A Registry-based Phase II Randomized Trial
SUPPRESS-NSCLC
NCT04405401
 Actif en recrutement
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
|
Diane Trudel
514-890-8000 poste 11181
|
(EN) A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients With Metastatic Non-Small-Cell Lung Cancer
IOV-LUN-202
NCT04614103
Actif en recrutement
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
|
Adeline Hamon
514-890-8000 poste 30737
|
(EN) Phase I Trial of Camu Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-Small Cell Lung Cancer and Melanoma
BR-2021-CamuCamu
NCT05303493
Actif en recrutement
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
|
Wiam Belkaid
514-890-8000
|
(EN) A Phase II Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIA) Non-small Cell Lung Cancer
NeoCOAST-2
NCT05061550
Actif en recrutement
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
|
Adeline Jouquan
514-890-8000 poste 26214
|
(EN) This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention
2023-11332
NCT05805319
Actif en recrutement
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
|
Wiam Belkaid
514-890-8000
|
(EN) A Randomized, Phase 3, Open-label Study to Evaluate Sigvotatug Vedotin Compared With Docetaxel in Adult Participants With Previously Treated Non-small Cell Lung Cancer
SGNB6A-002 (Be6A Lung-01)
NCT06012435
Actif en recrutement
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
|
Chantal Gosselin
514-890-8000 poste 24892
|
Marqueurs physiques et biologiques combinés pour la modélisation statistique des résultats de la radiothérapie dans le cancer du poumon non à petites cellules
Biomarqueurs
Actif en recrutement
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
|
Diane Trudel
514-890-8000 poste 11181
|
Étude de la fonction et du phénotype des lymphocytes infiltrant les tumeurs dans le cancer du poumon non à petites cellules.
CE13.335
Actif en recrutement
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
|
Adeline Jouquan
514-890-8000 poste 26214
|
(EN) Phase I Trial of Camu Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-Small Cell Lung Cancer and Melanoma
BR-2021-CamuCamu
NCT05303493
Actif en recrutement
|
CISSS DE LA MONTEREGIE-CENTRE
 HOPITAL CHARLES-LE MOYNE
|
|
Marilyn Tessier
450-466-5000 poste 7691
|
(EN) An Open-label, Multicenter, Phase 3 Randomized, Active-Comparator-Controlled Clinical Study of Pembrolizumab in Combination With Sacituzumab Govitecan Versus Pembrolizumab Monotherapy as First-line Treatment in Participants With PD L1 TPS Greater Than or Equal to 50% Metastatic Non-small Cell Lung Cancer
MK-3475-D46 (KEYNOTE D46/EVOKE-03)
NCT05609968
Actif en recrutement
|
CISSS DE LA MONTEREGIE-CENTRE
HOPITAL CHARLES-LE MOYNE
|
|
Marilyn Tessier
450-466-5000 poste 7691
|
Groupe d'étude en oncologie du Québec